These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 25564309)
1. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome. Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309 [TBL] [Abstract][Full Text] [Related]
2. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography. Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590 [TBL] [Abstract][Full Text] [Related]
3. Increased frequency of CCR7 Wu C; Yang P; Liu H; Xiao W; Zhao L Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636 [TBL] [Abstract][Full Text] [Related]
4. [B7-H4 expression of salivary gland and sera in patients with primary Sjogren's syndrome]. Yu DL; Li XM; Wang XM; Wang XQ; Li XP Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(39):2775-7. PubMed ID: 23290167 [TBL] [Abstract][Full Text] [Related]
6. Platelet serotonin in primary Sjögren's syndrome: level and relation with disease activity. Sarac H; Markeljevic J; Mokrovic G; Erdeljic V; Bozina N; Cicin-Sain L J Neuroimmunol; 2012 Oct; 251(1-2):87-9. PubMed ID: 22819441 [TBL] [Abstract][Full Text] [Related]
7. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association. Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474 [TBL] [Abstract][Full Text] [Related]
8. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro. Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214 [TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome. Kim SK; Choe JY; Lee GH Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771 [TBL] [Abstract][Full Text] [Related]
11. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175 [TBL] [Abstract][Full Text] [Related]
12. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome. Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203 [TBL] [Abstract][Full Text] [Related]
13. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome. Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome. Kovács L; Fehér E; Bodnár I; Marczinovits I; Nagy GM; Somos J; Boda V Clin Immunol; 2008 Aug; 128(2):269-76. PubMed ID: 18508410 [TBL] [Abstract][Full Text] [Related]
15. Growth Arrest-Specific 6 Protein in Patients with Sjögren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary Gland. Chen CH; Chen HC; Chang CC; Peng YJ; Lee CH; Shieh YS; Hung YJ; Lin YF PLoS One; 2015; 10(10):e0139955. PubMed ID: 26445266 [TBL] [Abstract][Full Text] [Related]
16. B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome. Li P; Yang Y; Jin Y; Zhao R; Dong C; Zheng W; Zhang T; Li J; Gu Z J Transl Med; 2019 Aug; 17(1):268. PubMed ID: 31412888 [TBL] [Abstract][Full Text] [Related]
17. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome. Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639 [TBL] [Abstract][Full Text] [Related]
18. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity. Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905 [TBL] [Abstract][Full Text] [Related]
19. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease. Andréasson K; Ohlsson B; Mandl T Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247 [TBL] [Abstract][Full Text] [Related]
20. Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjögren's syndrome. Gan X; Feng X; Gu L; Tan W; Sun X; Lv C; Zhang M Clin Dev Immunol; 2013; 2013():340751. PubMed ID: 23935647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]